Guangxi Wuzhou Zhongheng Group (600252.SH): Subsidiary plans to list and transfer its 34% equity stake in Fosun Nanning.

Guangxi Wuzhou Zhongheng Group (600252.SH) announced that its wholly-owned subsidiary Zhongheng Yixin Science and Technology Innovation Venture Capital Co., Ltd. ("Zhongheng Yixin") plans to transfer its 34% equity stake in Shanghai Fosun Pharmaceutical (Nanning) Co., Ltd. ("Fosun Nanning") through a public listing, with a listing price of no less than RMB11.1373 million. The final transaction amount and counterparty shall be subject to the results of the public listing transaction. After the completion of this equity transfer, Zhongheng Yixin will no longer hold any equity in Fosun Nanning. The completion of this listing and sale will help optimize the company's resource allocation and maximize asset value.